RNS
NKTR icon

Robert N. Shapiro’s Nektar Therapeutics NKTR Stock Holding History

Robert N. Shapiro’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$449K Hold
1,930
– – 0.09% 192
2014
Q3 		$349K Hold
1,930
– – 0.07% 214
2014
Q2 		$371K Hold
1,930
– – 0.07% 211
2014
Q1 		$351K Hold
1,930
– – 0.06% 209
2013
Q4 		$329K Hold
1,930
– – 0.06% 215
2013
Q3 		$302K Hold
1,930
– – 0.05% 219
2013
Q2 		$334K Buy
+1,930
New +$296K 0.07% 202

Other funds holding NKTR

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Robert N. Shapiro's NKTR Position: Q4 2014 in Review

Robert N. Shapiro held its Nektar Therapeutics (NKTR) position steady in Q4 2014 at 1,930 shares worth $449K. The position accounts for 0.09% of the portfolio, ranked #192.

Robert N. Shapiro first reported a position in NKTR in Q2 2013 and has held it in 7 quarters since. 163 funds tracked by Wall St. Rank hold NKTR as of Q4 2014.

  • Robert N. Shapiro held 1,930 shares of Nektar Therapeutics worth $449K as of Q4 2014.
  • Robert N. Shapiro left its Nektar Therapeutics share count unchanged in Q4 2014.
  • Nektar Therapeutics made up 0.09% of Robert N. Shapiro's portfolio in Q4 2014, its #192 holding.
  • Robert N. Shapiro first reported a position in Nektar Therapeutics in Q2 2013 and has held it in 7 quarters since.
  • 163 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2014.

Based on Robert N. Shapiro's 13F filing for Q4 2014, filed 19 Feb 2015.